CBLB and gastric cancer: The results suggest that miR‐141 targets Cbl‐b and c‐Cbl to prevent TRAF2‐mediated polyubiquitination and degradation of caspase‐8, and thus increases TRAIL sensitivity in gastric cancer cells.